Deletions at 11q identify a subset of patients with typical CLL who show consistent disease progression and reduced survival

Leukemia

Volumn 11, Issue 11, 1997, Pages 1929-1932

  Neilson, J R ^a   Auer, R ^a   White, D ^b   Bienz, N ^a   Waters, J J ^a   Whittaker, J A ^b   Milligan, D W ^a   Fegan, C D ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

CLL; Del(11q); Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER GROWTH; CANCER SURVIVAL; CHROMOSOME 11Q; CHROMOSOME 13Q; CHRONIC LYMPHATIC LEUKEMIA; GENE DELETION; HUMAN; HUMAN CELL; KARYOTYPE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0030706137     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400819     Document Type: Article

References (19)

1. Geisler CH, Philip P, Hansen MM. B-cell chronic lymphocytic leukemia: clonal chromosome abnormalities and prognosis in 89 cases, Eur J Haematol 1989; 43: 397-403.
2. Juliusson G, Oscier DG, Fitchett M, Ross FM, Stockdill G, Mackie MJ et al. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. New Engl J Med 1990; 323: 720-724.
3. Juliusson G, Gahrton G. Cytogenetics in CLL and related disorders. Ballières Clin Haematol 1993; 6: 821-848.
4. Fitchett M, Griffiths MJ, Oscier DJ, Johnson S, Seabright M. Chromosome abnormalities involving 13q14 in haematologic malignancies. Cancer Genet Cytogenet 1987; 24: 143-150.
5. Garcia-Marco J, Matutes R, Morilla J, Ellis D, Oscier J, Fantes D, Catovsky D, Price CM. Trisomy 12 in B-cell chronic lymphocytic leukemia: assessment of lineage restriction of simultaneous analysis and genotype in interphase cells by fluorescence in situ hybridisation. Br J Haematol 1994; 87: 44-50.
6. Escudier SM, Pereira-Leahy JM, Drach JW, Weier HU, Goodacre AM, Cork MA, Trujillo JM, Keating MJ, Andreeff M. Fluorescent in situ hybridisation and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia. Blood 1993; 81: 2702-2707.
7. Que TH, Garcia-Marco J, Ellis J, Matutes E, Brito-Babapulle V, Boyle S, Catovsky D. Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridisation: analysis by stage, immunophenotype, and morphology. Blood 1993; 82: 571-575.
8. Han T, Ozer H, Sadamori N, Emrich L, Gomez GA, Henderson ES, Bloom ML, Sandberg AA. Prognostic importance of cytogenetic abnormalities in patients with chronic lymphocytic leukemia. New Engl J Med 1984; 310: 288-292.
9. Pittman S, Catovsky D. Prognostic significance of chromosome abnormalities in chronic lymphocytic leukemia. Br J Haematol 1984; 58: 649-660.
10. Juliusson G, Robert K-H, Ost A, Friberg K, Biberfeld P, Nilsson B, Zech L, Gahrton G. Prognostic information from cytogenetic analysis in chronic B-lymphocytic leukemia and leukemic immunocytoma. Blood 1985; 65: 134-141.
11. Hernandez LM, Mecucci C, Criel A, Meeus P, Michaux L, Van Hoof A, Verhoef G, Louwagie A, Scheiff J-M, Michaux J-L, Boogaerts M, Van den Berghe H. Cytogenetic analysis of B-cell chronic leukemias classified according to morphological and immunophenotypic (FAB) criteria. Leukemia 1995; 9: 2140-2146.
12. Dohner H, Stilgenbauer S, Liebish P, Benner A, Schroder M, Weilguni T, Schlenk R, Fischer K, Bentz M, James MR, Lichter P. 11q deletions are the second most common chromosome aberration in B-cell chronic lymphocytic leukemia and are associated with advanced stages and marked lymphadenopathy. Blood 1995; 86 (Suppl 1.): 345a (Abstr.).
13. Fegan C, Robinson H, Thompson P, Whittaker JA, White D. Karyotypic evolution in CLL: identification of a new sub-group of patients with deletions of 11q and advanced or progressive disease. Leukemia 1995; 9: 2003-2008.
14. Criel A, Wlodarska I, Meeus P, Stul M, Louwagie A, Van Hoof A, Hidajat M, Mecucci C, Van den Berghe H. Trisomy 12 is uncommon in typical chronic lymphocytic leukemia. Br J Haemstol 1994; 87: 523-528.
15. Matutues E, Oscier D, Garcia-Marco J, Ellis J, Copplestone A, Gillingham R, Hamblin T, Lens D, Swansbury GT, Catovsky D. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol 1996; 92: 382-388.
16. Oscier DG, Stevens J, Hamblin TJ, Pickering RM, Lambert R, Fitchett M. Correlation of chromosome abnormalities with laboratory features and clinical course in B-cell chronic lymphocytic leukemia. Br J Haematol 1990; 76: 352-358.
17. Juliusson G, Gahrton G, Oscier D, Fitchett M, Ross F, Brito-Babapulle V, Catovsky D, Knuutila, Elonen E, Lechleitner M, Tanzer J, Schoenwald M, Castoldi GL, Cuneo A, Nowell P, Peterson L, Kay N. Cytogenetic findings and survival in B-cell chronic lymphocytic leukemia. Second IWCLL compilation of data on 662 patients. Leuk Lymphoma 1991; 5 (Suppl.): 21-25.
18. French Cooperative Group On Chronic Lymphocytic Leukaemia. Effects of chlorambucil and therapeutic decision in initial forms of chronic lymphocytic leukemia (stage A): results of randomised clinical trial on 612 patients. Blood 1990; 75: 1414-1422.
19. Stilgenbauer S, James MR, Liebisch P, Schroder M, Weilguni T, Bentz M, Schlegel berger B, Fischer K, Lichter P, Dohner H. Aberrations of chromosome 11q in chronic lymphoid neoplasms characterised by FISH. Blood 1995; 86 (Suppl. 1): 168a.